argon has been researched along with Asystole in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, F; Dickinson, R; Liang, M | 1 |
| Affatato, R; Babini, G; Bariselli, S; Belloli, A; Boccardo, A; Ceriani, S; Cucino, A; De Giorgio, D; Fiordaliso, F; Fumagalli, F; Furlan, R; Gobbi, M; Latini, R; Lucchetti, J; Luini, MV; Magliocca, A; Maisano, AM; Novelli, D; Olivari, D; Pravettoni, D; Ristagno, G; Russo, I; Sala, G; Salio, M; Scanziani, E; Staszewsky, L; Zani, D | 1 |
| Fries, M; Magliocca, A | 1 |
| Bleilevens, C; Brücken, A; Derwall, M; Föhr, P; Fries, M; Marx, G; Nolte, K; Rossaint, R | 1 |
| Belloli, A; De Maglie, M; Di Giancamillo, M; Fries, M; Fumagalli, F; Latini, R; Locatelli, V; Masson, S; Novelli, D; Ristagno, G; Russo, I; Scanziani, E; Staszewsky, L; Tantillo, S; Vago, T; Zani, DD | 1 |
| Jackson, TC; Kochanek, PM | 1 |
| Bleilevens, C; Brücken, A; Derwall, M; Fries, M; Kurnaz, P; Nolte, K; Rossaint, R; Weis, J | 2 |
| Grandgirard, D; Grossholz, M; Haenggi, M; Jakob, S; Leib, SL; Springe, D; Takala, J; Zuercher, P | 1 |
| Brücken, A; Cizen, A; Fera, C; Fries, M; Marx, G; Meinhardt, A; Nolte, K; Pufe, T; Rossaint, R; Weis, J | 1 |
| Kim, JH; Lee, SY; Min, SK | 1 |
| Fujiwara, Y; Kitahara, M; Kono, M; Ohmura, A; Sha, M; Yahagi, N | 1 |
2 review(s) available for argon and Asystole
| Article | Year |
|---|---|
Neuroprotection by the noble gases argon and xenon as treatments for acquired brain injury: a preclinical systematic review and meta-analysis.
Topics: Animals; Argon; Brain Injuries; Brain Ischemia; Heart Arrest; Mice; Neuroprotection; Neuroprotective Agents; Noble Gases; Rats; Stroke; Swine; Xenon | 2022 |
Inhaled gases as novel neuroprotective therapies in the postcardiac arrest period.
Topics: Animals; Argon; Clinical Trials, Phase II as Topic; Heart Arrest; Humans; Hypothermia, Induced; Neuroprotection; Neuroprotective Agents; Randomized Controlled Trials as Topic; Swine; Xenon | 2021 |
10 other study(ies) available for argon and Asystole
| Article | Year |
|---|---|
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs.
Topics: Animals; Argon; Biomarkers; Brain; Brain Injuries; Cardiopulmonary Resuscitation; Case-Control Studies; Heart Arrest; Hemodynamics; Male; Models, Animal; Neuroprotective Agents; Nitrogen; Oxygen; Recovery of Function; Safety; Survival Analysis; Swine; Treatment Outcome; Ventilation | 2020 |
Influence of argon on temperature modulation and neurological outcome in hypothermia treated rats following cardiac arrest.
Topics: Animals; Argon; CA1 Region, Hippocampal; Cardiopulmonary Resuscitation; Disease Models, Animal; Heart Arrest; Hypothermia, Induced; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function | 2017 |
Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest.
Topics: Animals; Argon; Brain Ischemia; Cardiopulmonary Resuscitation; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Arrest; Hemodynamics; Hippocampus; Male; Myocardial Infarction; Neuroprotective Agents; Sus scrofa; Treatment Outcome | 2014 |
Will the next breakthrough for neuroprotection after cardiac arrest come out of thin air?
Topics: Animals; Argon; Brain Ischemia; Cardiopulmonary Resuscitation; Heart Arrest; Male; Neuroprotective Agents | 2014 |
Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening.
Topics: Animals; Argon; Brain Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Arrest; KATP Channels; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2014 |
Delayed argon administration provides robust protection against cardiac arrest-induced neurological damage.
Topics: Animals; Argon; Behavior, Animal; Brain Injuries; Disease Models, Animal; Heart Arrest; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley | 2015 |
A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model.
Topics: Animals; Argon; Heart Arrest; Helium; Hippocampus; Male; Neuroprotection; Neuroprotective Agents; Noble Gases; Oxygen; Rats; Rats, Wistar | 2016 |
Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats.
Topics: Administration, Inhalation; Animals; Argon; Cardiopulmonary Resuscitation; Drug Evaluation, Preclinical; Heart Arrest; Hippocampus; Hypoxia-Ischemia, Brain; Male; Maze Learning; Neocortex; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function | 2013 |
Carbon dioxide and argon gas embolism during laparoscopic hepatic resection.
Topics: Argon; Carbon Dioxide; Cholestasis, Intrahepatic; Echocardiography, Transesophageal; Embolism, Air; Female; Heart Arrest; Humans; Intraoperative Complications; Laparoscopy; Liver; Middle Aged; Oximetry; Postoperative Complications; Pulmonary Edema | 2007 |
Cardiac arrest associated with use of an argon beam coagulator during laparoscopic cholecystectomy.
Topics: Aged; Aged, 80 and over; Argon; Cholecystectomy, Laparoscopic; Electrocoagulation; Embolism, Air; Female; Heart Arrest; Humans | 2001 |